Clinical trial
Calcitriol Plus Paclitaxel in Treating Patients With Advanced Solid Tumors
NCT00009802 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00009802 |
|---|---|
| Title | Calcitriol Plus Paclitaxel in Treating Patients With Advanced Solid Tumors |
| Official title | A Phase I Trial Of Oral Calcitriol [1,25-(OH)2D3] And Paclitaxel In Advanced Solid Tumors |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Dietary Supplement, Drug |
| Interventions | calcitriol, paclitaxel |
| Enrollment | 45 |
| Start date | Jun 1, 1998 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Jun 6, 2003 |
| Last update posted | Dec 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: